{"canonical":"https://abierto.us/vendors/gritstone-bio-inc-wpnlfzk8ma87","key":"WPNLFZK8MA87","name":"GRITSTONE BIO, INC.","uei":"WPNLFZK8MA87","city":"EMERYVILLE","state":"CA","awards":1,"obligated":"0","notices_won":0,"top_agency_name":"Office of Assistant Secretary for Preparedness and Response","top_naics":"541714","cage":"9L4G1","parent_name":"GRITSTONE BIO, INC.","also_known_as":[],"country":"USA","actions":3,"first_action":"2024-03-11","last_action":"2026-03-12","breakdowns":{"naics":[{"key":"541714","name":null,"awards":1,"obligated":"0.00"}],"places":[{"key":"MA","name":null,"awards":1,"obligated":"0.00"}],"agencies":[{"key":"7505","name":"Office of Assistant Secretary for Preparedness and Response","awards":1,"obligated":"0.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":1,"obligated":"0.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":1,"obligated":"0.00"}],"product_service_codes":[{"key":"AN14","name":null,"awards":1,"obligated":"0.00"}]},"awards_list":[{"award_key":"CONT_AWD_75A50123C00062_7505_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75A50123C00062_7505_-NONE-_-NONE-/","piid":"75A50123C00062","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"WPNLFZK8MA87","recipient_name":"GRITSTONE BIO, INC.","recipient_uei":"WPNLFZK8MA87","recipient_cage":"9L4G1","recipient_city":"EMERYVILLE","recipient_state":"CA","sub_name":"Office of Assistant Secretary for Preparedness and Response","office_name":"BARDA - ASPR / DAAPPO / BARDA DCMA","office_key":"o-75A501","first_action_date":"2024-03-11","last_action_date":"2026-03-12","actions":3,"obligated":"0","current_total_value":"9856008.00","potential_total_value":"433190532.00","naics":"541714","psc":"AN14","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"DEVELOPING A NEXT-GENERATION VACCINE THAT DRIVES (A) MORE DURABLE AND BROAD ANTI-SPIKE NEUTRALIZING ANTIBODIES (NABS) AGAINST VARIANTS OF CONCERN (VOCS), INCLUDING THOSE NOT INCLUDED IN THE VACCINE, AND (B) T CELLS REACTIVE AGAINST CONSERVED TARGETS","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":1,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}